SPIDITS
Open Live Timeline
Funding
Chai Discovery Nabs $400M Series C as AI-designed Antibodies Reach Big Pharma
Summary
- Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion.
Why It Matters
Exposes critical gaps in AI platform safety measures and raises urgent questions about accountability, content moderation, and the real-world consequences of generative AI misuse.
Referenced Coverage & Sources
Track Live AI Developments on SPIDITS
Explore model releases, funding rounds, and technical breakthroughs curated in real-time by spidits.com's autonomous AI analysis engine.